Is age of onset and duration of stimulant therapy for ADHD associated with cocaine, methamphetamine, and prescription stimulant misuse?
Journal of Child Psychology and Psychiatry · 2024-01 · 65 (1) · 100-111
DOI: 10.1111/jcpp.13807 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Child Psychology and Psychiatry, online erschienen am 16.04.2023. Verfasst von Sean Esteban McCabe und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health Behavior and Biological Sciences, University of Michigan, Ann Arbor, MI, USA. Hauptthemen laut MEDLINE: Methamphetamine, Attention Deficit Disorder with Hyperactivity, Central Nervous System Stimulants, Substance-Related Disorders. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIDA NIH HHS, NICHD NIH HHS, National Institute on Drug Abuse.
Abstract (Originalsprache)
Background
To assess whether age of onset and duration of stimulant therapy for attention‐deficit/hyperactivity disorder (ADHD) are associated with cocaine, methamphetamine, and prescription stimulant misuse during adolescence.
Methods
Nationally representative samples of US 10th and 12th grade students ( N = 150,395) from the Monitoring the Future study were surveyed via self‐administered questionnaires from 16 annual surveys (2005–2020).
Results
An estimated 8.2% of youth received stimulant therapy for ADHD during their lifetime ( n = 10,937). More than one in 10 of all youth reported past‐year prescription stimulant misuse (10.4%)—past‐year cocaine (4.4%) and methamphetamine (2.0%) use were less prevalent. Youth who initiated early stimulant therapy for ADHD (≤9 years old) and for long duration (≥6 years) did not have significantly increased adjusted odds of cocaine or methamphetamine use relative to population controls (ie, non‐ADHD and unmedicated ADHD youth). Youth who initiated late stimulant therapy for ADHD (≥10 years old) and for short duration (
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Health Behavior and Biological Sciences, University of Michigan, Ann Arbor, MI, USA.
- University of Michigan, School of Medicine, Ann Arbor, MI, USA.
- Texas State University, San Marcos, TX, USA.
- University of Michigan - Institute for Social Research, Ann Arbor, MI, USA.
- University of Michigan-Systems, Populations, and Leadership, Ann Arbor, MI, USA.
- Wayne State University School of Medicine-Psychiatry, Detroit, MI, USA.
ORCID-Profile: Sean Esteban McCabe
Förderung
- NIDA NIH HHS
- NICHD NIH HHS
- National Institute on Drug Abuse
- U.S. Food and Drug Administration
Zitieren
APA
McCabe, S. E., Figueroa, O., McCabe, V. V., Schepis, T. S., Schulenberg, J. E., Veliz, P. T., Werner, K. S., & Wilens, T. E. (2024). Is age of onset and duration of stimulant therapy for ADHD associated with cocaine, methamphetamine, and prescription stimulant misuse?. Journal of Child Psychology and Psychiatry, 65(1), 100-111. https://doi.org/10.1111/jcpp.13807
Vancouver
McCabe SE, Figueroa O, McCabe VV, Schepis TS, Schulenberg JE, Veliz PT, et al. Is age of onset and duration of stimulant therapy for ADHD associated with cocaine, methamphetamine, and prescription stimulant misuse?. Journal of Child Psychology and Psychiatry. 2024;65(1):100-111. doi:10.1111/jcpp.13807
BibTeX
@article{McCabe2024,
author = {McCabe, Sean Esteban and Figueroa, Olivia and McCabe, Vita V and Schepis, Ty S and Schulenberg, John E and Veliz, Philip T and Werner, Kennedy S and Wilens, Timothy E},
title = {Is age of onset and duration of stimulant therapy for ADHD associated with cocaine, methamphetamine, and prescription stimulant misuse?},
journal = {Journal of Child Psychology and Psychiatry},
year = {2024},
volume = {65},
number = {1},
pages = {100--111},
doi = {10.1111/jcpp.13807}
}
EUVIMED